NEW YORK, April 14, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding
Marketo, Inc. (NASDAQ: MKTO), Dealertrack Holdings, Inc. (NASDAQ:
TRAK), Cypress Semiconductor Corporation (NASDAQ: CY), Allscripts
Healthcare Solutions, Inc. (NASDAQ: MDRX), and Integrated Device
Technology, Inc. (NASDAQ: IDTI). Private wealth members receive
these notes ahead of publication. To reserve complementary
membership, limited openings are available at:
http://www.analystsreview.com/1034-100free
--
Marketo, Inc. Analyst Notes
On April 9, 2014, Marketo, Inc.
(Marketo) announced the winners of its annual Revvie Awards, which
recognizes Marketo customers, partners, and individual marketers
who created significant impact on revenue and enriched customer
relationships through their innovative use of the Company's
customer engagement platform. According to the Company, three of
its customers, Acquia, Kaiser Permanente of Colorado, and Curves each won the "Most
Dramatic Business Impact" award, while some of the Company's
partners and individual marketers have been recognized for
utilizing Marketo's software to yield substantial results for their
clients and companies. Marketo awarded Datarati, The Pedowitz
Group, Christine Nurnberger of
Sungard Availability Services, Sarah
Shelnut, and Egencia's Acquisition Marketing Manager,
Jeff Shearer for their contributions
to the Company. Marketo presented the awards at the 2014 Marketing
Nation Summit. The full analyst notes on Marketo, Inc. are
available to download free of charge at:
http://www.analystsreview.com/1034-MKTO-14Apr2014.pdf
--
Dealertrack Holdings, Inc. Analyst Notes
On April 9, 2014, DealerTrack
Holdings, Inc. (Dealertrack) announced that Dealertrack Canada
completed the launch of its advanced finance portal for Hyundai
Auto Canada Corporation and all of Hyundai automobile dealers.
According to the Company, the new Hyundai-branded portal, powered
by Dealertrack, will be directly and seamlessly integrated into the
OEM's systems to enable credit application submissions and deliver
real-time data updates, including latest incentives and aftermarket
offerings, new inventory and CPO program data to Hyundai dealers
who are financing transactions through the Dealertrack Network. The
full analyst notes on DealerTrack Holdings, Inc. are available to
download free of charge at:
http://www.analystsreview.com/1034-TRAK-14Apr2014.pdf
--
Cypress Semiconductor Corporation Analyst Notes
On April 2, 2014, Cypress
Semiconductor Corporation (Cypress) announced the retirement of
Executive Vice President and Chief Financial Officer Brad Buss after eight years of service, who will
remain in position through June 1,
2014. According to Cypress, current Vice President of
Finance Thad Trent will assume the
role of EVP and CFO. The Company stated that Buss will continue to
assist in the transition on a part-time basis through September 1, 2014, after which he will become a
non-employee advisor to the Board and the CEO through April 30, 2015. Cypress said that Thad Trent has 22 years of experience in the
technology industry and has held finance management roles at
publicly traded companies Wind River Systems and Wyle Electronics,
as well as two technology startups before joining Cypress in 2005,
where he served as Vice President in 2010. The full analyst notes
on Cypress Semiconductor Corporation are available to download free
of charge at:
http://www.analystsreview.com/1034-CY-14Apr2014.pdf
--
Allscripts Healthcare Solutions, Inc. Analyst
Notes
On April 9, 2014, Allscripts
Healthcare Solutions, Inc. (Allscripts) announced that Lakeland
Regional Health Systems (LRHS) expanded its use of Allscripts suite
of electronic health record (EHR) solutions and services for
hospitals and clinics. The Company stated that Allscripts
TouchWorks™ is a powerful, multi-specialty ambulatory solution that
offers automated clinical decision support at the point of care, a
configurable clinical desktop, and nearly 800 peer-reviewed Care
Guides. In addition, the Company stated that it is a highly
customizable solution with an open architecture and efficient
workflows that can help improve the patient experience. According
to Allscripts, LHRS expands the use of Allscripts TouchWorks™
ambulatory EHR and Allscripts Practice Management™ clinical and
operational solutions, use Allscripts managed services, and
implement Allscripts Payerpath™ financial management software to
help meet the organization's complex business needs of a growing
clinical practice and patient population. The full analyst notes on
Allscripts Healthcare Solutions, Inc. are available to download
free of charge at:
http://www.analystsreview.com/1034-MDRX-14Apr2014.pdf
--
Integrated Device Technology, Inc. Analyst
Notes
On April 3, 2014, Integrated
Device Technology, Inc. (IDT) announced that its industry-leading
timing solution, the 8T49N28x Universal Frequency Translator (UFT)
clocking family, received a 2014 Annual Creativity in Electronics
(ACE) Award in the 'Ultimate Products' category presented by UBM
Tech's EE Times and EDN, two prestigious industry publications.
According to IDT, the 8T49N28x UFT family is the first single-chip
programmable solution in the industry capable of generating eight
different output frequencies with less than 300 fs RMS phase jitter
over the standard 12kHz to 20MHz integration range. The full
analyst notes on Integrated Device Technology, Inc. are available
to download free of charge at:
http://www.analystsreview.com/1034-IDTI-14Apr2014.pdf
--
About Analysts Review
We provide our members with a simple and reliable way to leverage
our economy of scale. Most investors do not have time to track all
publicly traded companies, much less perform an in-depth review and
analysis of the complexities contained in each situation. That's
where Analysts Review comes in. We provide a single unified
platform for investors' to hear about what matters. Situation
alerts, moving events, and upcoming opportunities.
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
- This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
- If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us
at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Analysts Review. An outsourced research services provider
represented by Nidhi Vatsal, CFA, has only reviewed the information
provided by Analysts Review in this article or report according to
the Procedures outlined by Analysts Review. Analysts Review is not
entitled to veto or interfere in the application of such procedures
by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to
the accuracy or completeness or fitness for a purpose (investment
or otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Analysts Review
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Analysts Review expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Analysts Review does not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Analysts Review